Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylsulfanyl)phenyl)-1h-pyrrol-1-yl(ethoxy)phenyl)propanoic Acid
2. (2s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylsulfanyl)phenyl)-1h-pyrrol-1-yl(ethoxy)phenyl)propanoic Acid Magnesium Salt (2:1)
3. Alpha-ethoxy-4-(2-(2-methyl-5-(4-methylthio)phenyl))-1h-pyrrol-1-yl)ethoxy))benzenepropanoic Acid
4. Alpha-ethoxy-4-(2-(2-methyl-5-(4-methylthio)phenyl))-1h-pyrrol-1-yl)ethoxy))benzenepropanoic Acid Magnesium Salt
5. Lipaglyn
6. Saroglitazar Magnesium
7. Zyh1 Compound
1. 495399-09-2
2. Lipaglyn
3. Zyh1
4. Saroglitazar [inn]
5. (s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1h-pyrrol-1-yl)ethoxy)phenyl)propanoic Acid
6. E0ymx3s4jd
7. 495399-09-2 (free)
8. (2s)-2-ethoxy-3-[4-[2-[2-methyl-5-(4-methylsulfanylphenyl)pyrrol-1-yl]ethoxy]phenyl]propanoic Acid
9. Unii-e0ymx3s4jd
10. Saroglitazarum
11. Saroglitazar [who-dd]
12. Chembl4297530
13. Schembl16346340
14. Dtxsid10197819
15. Chebi:134708
16. Bcp25470
17. Vua39909
18. Mfcd28502034
19. S9674
20. Cs-6149
21. Db13115
22. (2s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylsulfanyl)phenyl)-1h-pyrrol-1-yl(ethoxy)phenyl)propanoic Acid
23. Hy-19937
24. P14958
25. A913988
26. Q15269693
27. (2s)-2-ethoxy-3-[4-(2-{2-methyl-5-[4-(methylthio)phenyl]-1h-pyrrol-1-yl}ethoxy)phenyl]propanoic Acid
28. (s)-alpha-ethoxy-4-[2-[-methyl-5-[4-(methylthio) Phenyl]-1h-pyrrol-1-yl]ethoxy]benzene-propanoic Acid
29. Benzenepropanoic Acid, .alpha.-ethoxy-4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1h-pyrrol-1-yl)ethoxy)-, (.alpha.s)-
| Molecular Weight | 439.6 g/mol |
|---|---|
| Molecular Formula | C25H29NO4S |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 11 |
| Exact Mass | 439.18172958 g/mol |
| Monoisotopic Mass | 439.18172958 g/mol |
| Topological Polar Surface Area | 86 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 532 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Saroglitazar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Saroglitazar, including repackagers and relabelers. The FDA regulates Saroglitazar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Saroglitazar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Saroglitazar manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Saroglitazar supplier is an individual or a company that provides Saroglitazar active pharmaceutical ingredient (API) or Saroglitazar finished formulations upon request. The Saroglitazar suppliers may include Saroglitazar API manufacturers, exporters, distributors and traders.
click here to find a list of Saroglitazar suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Saroglitazar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Saroglitazar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Saroglitazar GMP manufacturer or Saroglitazar GMP API supplier for your needs.
A Saroglitazar CoA (Certificate of Analysis) is a formal document that attests to Saroglitazar's compliance with Saroglitazar specifications and serves as a tool for batch-level quality control.
Saroglitazar CoA mostly includes findings from lab analyses of a specific batch. For each Saroglitazar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Saroglitazar may be tested according to a variety of international standards, such as European Pharmacopoeia (Saroglitazar EP), Saroglitazar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Saroglitazar USP).
LOOKING FOR A SUPPLIER?
